Weight Loss / Metabolic
Tirzepatide
Dual Agonist (GLP-1/GIP)
$199/month
Tirzepatide is a first-in-class dual incretin agonist targeting both GLP-1 and GIP receptors for superior appetite control and metabolic improvement.
Key Benefits
Dual receptor action
Superior appetite control
Improved insulin sensitivity
Sustainable weight loss
Dosing
Weekly subcutaneous injection, dose titration protocol
Ingredients
Tirzepatide
Ideal For
- •Men seeking weight loss
What to Expect
Weeks 1-4
1
Reduced appetite and cravings
* Individual results may vary. Consistent use and healthy lifestyle choices enhance outcomes.
Related Products
Ready to start with Tirzepatide?
Take our eligibility quiz to see if this treatment is right for you.
